Lupeng Pharmaceutical is based in Guangzhou, China. It has raised $59M in total funding. Backed by Temasek, Lake Bleu Capital, Lilly Asia Ventures (LAV).
Lupeng Pharmaceutical funding overview
Lupeng Pharmaceutical is based in Guangzhou, China. Lupeng Pharmaceutical has raised $59M in total disclosed funding. That places its disclosed total in the $25M–$100M range. The round record for Lupeng Pharmaceutical runs through 2021; nothing later has been disclosed. Investors on record include Temasek, Lake Bleu Capital, Lilly Asia Ventures (LAV), Fontus Capital. 4 distinct backers are named across the disclosed rounds.
Lupeng Pharmaceutical at a glance
Total raised
$59M
Latest round date
July 2021
Headquarters
Guangzhou, China
Notable investors
Temasek, Lake Bleu Capital, Lilly Asia Ventures (LAV), Fontus Capital
Frequently asked about Lupeng Pharmaceutical funding
How much has Lupeng Pharmaceutical raised?
Lupeng Pharmaceutical has raised $59M in total disclosed funding across the rounds on record.
Who has invested in Lupeng Pharmaceutical?
Temasek, Lake Bleu Capital, Lilly Asia Ventures (LAV), Fontus Capital are named among the investors backing Lupeng Pharmaceutical.
What was the latest Lupeng Pharmaceutical funding round?
No round stage has been disclosed for Lupeng Pharmaceutical.
Where is Lupeng Pharmaceutical based?
Lupeng Pharmaceutical is based in Guangzhou, China.
When did Lupeng Pharmaceutical last raise?
The last disclosed Lupeng Pharmaceutical round closed in July 2021.
Round data for Lupeng Pharmaceutical is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Guangzhou and backer lists below.
